UNSPSC 51383402: Etodolac
Commodity
Code facts
- Part of
-
-
51000000
-
51380000
- 51383400
-
51380000
-
51000000
- NIGP codes
- 1
UNSPSC codes and definitions come from the UN Development Programme (managed by GS1 US), and state and local contract opportunities from the governments' procurement sites.
NIGP codes for 51383402
Definition
This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C17H21NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2M36281008, chemically known as 1,3,4,9-tetrahydro-1,8-diethylpyrano(3,4-b)indole-1-acetic acid but generally known as etodolac, which bears US NIH Compound Identifier 3308. European Medicines Agency schedules Etodolac in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07316MIG.
Read the full definition
The term ETODOLAC is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 35, No. 5 1981, List 21). World Health Organization schedules etodolac in its Anatomical Therapeutic Chemical (ATC) Classification. ETODOLAC is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule etodolac under HS 29349990 and SITC 51579. As of Q4 2014, ETODOLAC remains the US FDA Preferred Term for this commodity. Etodolac bears US NLM identifiers UMLS ID C0059865 and NCI Concept Code C47526.
SMILES: O1C(C2[NH]C3C(C2CC1)CCCC3CC)(CC)CC(=O)O.
About UNSPSC 51383402
UNSPSC 51383402 Etodolac is a Commodity code that nominally refers to a specific nonsteroidal anti-inflammatory drug, yet the recent state and local procurement activity shows a fundamental mismatch. Seminole County, Florida's only recent solicitation tagged to this code—IFB 60459723LAS, posted June 30, 2026—actually seeks Naloxone and Safe Drug Deactivation Systems for community health initiatives, not Etodolac. The discrepancy suggests either a cataloging error in the county's e-Procurement system or a significant divergence between the code's intended scope and how it is being applied in practice. Without additional recent opportunities under this code, the true scope of work being purchased by state and local governments under UNSPSC 51383402 cannot be reliably characterized.
The Seminole County procurement is the sole recent opportunity available. The county issued an IFB with a response deadline of July 26, 2023 (note: the posting date of June 30, 2026 conflicts with the deadline year, indicating a possible data-entry error in the source), requiring 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The contract carries a two-year initial term with a one-year renewal option, fixed pricing, and standard compliance requirements including drug-free workplace certification, E-Verify authorization, and federal regulatory adherence. No recent activity from other state or local jurisdictions is present in the available record. Given the single, off-code opportunity and the absence of a reliable activity baseline, this code presents minimal visibility for business development purposes at this time.
Quick answers
What is UNSPSC 51383402?
UNSPSC 51383402 is Etodolac, a commodity in UNSPSC 51000000, Pharmaceutical Products incl. Contraceptives and Vaccines.
Which NIGP codes match UNSPSC 51383402?
UNSPSC 51383402 maps to 1 NIGP code, 26928 Central Nervous System Agents (Including: Analegsic, Anticonvulsant, Antidepressant, Antihistamine, Antipsychotic and Sedative).
On GovTribe
See everything under UNSPSC 51383402
- State & local contract opportunities, awards and contract vehicles under this code
- Contacts who buy under this code
- Ask GovTribe AI about this code